Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D-Reference-Cited by-同舟云学术

Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D

Published:2022-10 Issue: Volume:65 Page:32-40
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Graffeo R.^ORCID,Rana H.Q.,Conforti F.,Bonanni B.^ORCID,Cardoso M.J.,Paluch-Shimon S.,Pagani O.,Goldhirsch A.,Partridge A.H.^ORCID,Lambertini M.^ORCID,Garber J.E.

Funder

American Society of Clinical Oncology

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference75 articles.

1. Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population;Manchanda;J Med Genet,2018

2. Management of hereditary breast cancer: American society of clinical oncology, American society for radiation oncology, and society of surgical oncology guideline;Tung;J Clin Oncol,2020

3. Management of women with breast cancer and pathogenic variants in genes other than BRCA1 or BRCA2;Robson;J Clin Oncol,2021

4. ESO-ESMO 4th international consensus guidelines for breast cancer in young women (BCY4);Paluch-Shimon;Ann Oncol,2020

5. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening;Paluch-Shimon;Ann Oncol,2016

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Own Experience of Using Next-Generation Sequencing in the Diagnosis of BRCA-Associated Breast Cancer;Ural Medical Journal;2024-09-03

2. Mutation Spectrum Comparison between Benign Breast Lesion Cohort, Unselected Cancer Cohort and High-Risk Breast Cancer Cohort;Cancers;2024-09-03

3. Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2;Critical Reviews in Oncology/Hematology;2024-09

4. Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1/2 genes;Cancer Treatment Reviews;2024-09

5. Molecular genetic investigation of hereditary breast and ovarian cancer patients in the Southern Transdanubian region: widening the mutation spectrum and searching for new pathogenic variants using next-generation methods;Pathology and Oncology Research;2024-08-01